Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservation
B Henriques De Figueiredo, C Fortpied, J Menis, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
P Gimel, M Gross-Goupil, L Geoffrois, et al.
Journal of the National Cancer Institute
|
January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy
J L Lefebvre, F Rolland, M Tesselaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
J J Knox, C H Barrios, T M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
J J Knox, C H Barrios, T M Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
Y Loriot, L Pagliaro, A Fléchon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2014
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
F Selle, S Wittnebel, P Biron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Bulletin Du Cancer
|
October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]
J Thariat, F Jegoux, Y Pointreau, et al.
Annales De Dermatologie Et De Venereologie
|
September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)
F Skowron, S Mouret, A Seigneurin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2016
Long-term update of the 24954 EORTC phase III trial on larynx preservation
B Henriques De Figueiredo, C Fortpied, J Menis, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
P Gimel, M Gross-Goupil, L Geoffrois, et al.
Journal of the National Cancer Institute
|
January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy
J L Lefebvre, F Rolland, M Tesselaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
J J Knox, C H Barrios, T M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
J J Knox, C H Barrios, T M Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
Y Loriot, L Pagliaro, A Fléchon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2014
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
F Selle, S Wittnebel, P Biron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Bulletin Du Cancer
|
October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]
J Thariat, F Jegoux, Y Pointreau, et al.
Annales De Dermatologie Et De Venereologie
|
September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)
F Skowron, S Mouret, A Seigneurin, et al.
Page
of 4